Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
0.700 | 1.000 | 9 | 2001 | 2016 | |||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 8 | 2001 | 2016 | ||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2002 | 2014 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2002 | 2014 | |||||||
|
1.000 | 0.040 | 13 | 108207498 | 3 prime UTR variant | C/T | snv | 0.12 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2001 | 2014 | ||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2001 | 2014 | ||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
Musculoskeletal Diseases; Nervous System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2001 | 2014 | ||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2001 | 2014 | ||||||
|
0.807 | 0.360 | 13 | 108208829 | stop gained | G/A | snv | 9.9E-05 | 7.0E-05 |
|
0.700 | 1.000 | 2 | 2001 | 2014 | |||||||
|
1.000 | 0.160 | 13 | 108209863 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Immune System Diseases | 0.810 | 1.000 | 2 | 2001 | 2004 | ||||||||
|
0.882 | 0.200 | 13 | 108210436 | missense variant | C/A;T | snv | 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Immune System Diseases | 0.810 | 1.000 | 2 | 2001 | 2010 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2004 | 2012 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2004 | 2012 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2004 | 2012 | |||||||
|
0.851 | 0.280 | 13 | 108210371 | missense variant | C/T | snv | 1.6E-04 | 2.1E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2010 | 2012 | ||||||
|
0.790 | 0.120 | 13 | 108211243 | missense variant | G/A | snv | 0.18 | 0.16 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2013 | 2015 | ||||||
|
0.790 | 0.120 | 13 | 108211243 | missense variant | G/A | snv | 0.18 | 0.16 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2009 | 2012 | ||||||
|
1.000 | 0.040 | 13 | 108207498 | 3 prime UTR variant | C/T | snv | 0.12 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 13 | 108207498 | 3 prime UTR variant | C/T | snv | 0.12 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.160 | 13 | 108209531 | stop gained | G/A;C | snv | 8.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Immune System Diseases | 0.710 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.882 | 0.200 | 13 | 108210436 | missense variant | C/A;T | snv | 1.2E-05 |
|
0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.882 | 0.200 | 13 | 108210436 | missense variant | C/A;T | snv | 1.2E-05 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.776 | 0.280 | 13 | 108210293 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |